what is bronchitis

Info about bronchitis coughing => bronchitis cures => Topic started by: glennaguilar on August 11, 2016, 10:53:42 pm


Title: Severe Bronchitis Causes and the Bronchial Respiratory
Post by: glennaguilar on August 11, 2016, 10:53:42 pm
Severe Bronchitis Causes - the Bronchial Respiratory Disease
Bronchitis designates the inflammation of the bronchial tree evolving with an excessive mucus secretion. It is an acute or chronic condition caused by bacterial, fungal or viral infections but also by allergens especially smoking.

Long-term smoking can directly lead to chronic bronchitis and different respiratory harming factors can make the bronchial tree vulnerable to bronchitis and fibrosis. Chronic bronchitis is usually connected to the pulmonary emphysema meaning mass pulmonary disruptions. It is rather interesting to note that people like reading about Bronchitis Acute if they are presented in an easy and clear way. The presentation of an article too is important for one to entice people to read it!

While the bronchitis attacks, patients are not allowed to eat dairy products as they increase the secretion of mucus and worsen the infection by stimulating the multiplication of bacteria.

Treating the bronchitis is mainly done by administering drugs to increase the volume of bronchial tubes, to calm coughing; infection is treated by antibiotics but a complete cure would be also giving up smoking.

Quote
Acute bronchitis has the signs of a chest cold: fever, dry or mucus expectorating coughing, feeble voice, speak problems, chest pain, nausea, and anorexia. Acute bronchitis is caused by bronchial inflammation is usually self-limiting. Symptoms can sometimes be impossible to detect because of the constricted contractions of the respiratory system. If not treated in time, acute bronchitis gives complications like chronicisation, asthmatic bronchitis; most dangerous are cases in children, newborns or adults suffering from emphysema. The presentation of an article on Chronic Bronchitis Patients plays an important role in getting the reader interested in reading it. This is the reason for this presentation, which has gotten you interested in reading it!

Is known that bronchitis can appear because of an infection from bacteria or virus, and these are causes that make this illness contagious. Patients with bronchitis have inflammation of the bronchial tubes, or bronchi located in the chest of human body, and this can result in discharge of phlegm or sputum.  Some causes of bronchitis are dust and air pollution, but especially smoking. It was seen that cigarettes smokers are the most affected by this illness.  Usually bronchitis appears in winter, but when it becomes chronic, it can continue during the year.

There are a Lot of Signs of Bronchitis
We can mention severe cough, that appears during the morning of the winter months, while coughing there is a large amount of cough that comes, and another sign of being infected with this disease is yellow sputum discharged during coughing. It must be said that patients with bronchitis complain tightness of the chest, they get fever when infected, and there can appear breathlessness, which will lead to exertion.

To treat bronchitis, you can use some home remedies like honey with a tea spoon of ginger juice, or a liquid mixture of tulsi, ginger and black pepper in same proportion and must be taken 20-25 ml 3 times a day.  You can also increase the intake of water, because that will help to make the mucus in the lungs thin and in this way cough clears out easily, and while going to bed or before breakfast you can take with sugar and honey the mixture that results after boiling 1 tea spoon of Jushanda in a cup of water.  You should also avoid smoking, because it irritates lungs and slows down healing; in order to relax sore chest muscles and obtain faster relief you can massage your chest and back muscles, and it was seen that Mulathi if chewed for some time helps.  It is important to know that we must overcome the sources of irritation and infection in the throat, nose, sinuses, mouth, and bronchial tubes. Staying indoor during the cold weather may be of real help, and also avoiding any sort of polluted air and dusty working conditions. Just as a book shouldn't be judged by its cover, we wish you read this entire article on Bronchitis Contagious before actually making a judgement about Bronchitis Contagious.

Chronic bronchitis is defined as a long term inflammation or swelling of the bronchi.' This can result in heightened production of mucus and may be accompanied by other side effects.' To be classified as chronic bronchitis, a harsh cough and expectoration (coughing up of mucus) must occur on most days, for no less than three months of the year, for two or more years in a row.' This does not include other conditions such as pneumonia, tuberculosis, or other lung conditions that may result in the same symptoms.

Identifying the Symptoms of Chronic Bronchitis  Although chronic bronchitis may affect each person differently, there are tell-tale signs of chronic bronchitis that may help you identify the problem.' These include:

Pulse Oximetry
Measures the amount of oxygen present in the blood.  -Arterial Blood Gas (ABG) - An ABG is a blood test that measures the acidity (pH) of the blood and also measures the lungs' ability to provide your blood with oxygen and remove carbon dioxide from it. :o.

What Causes Chronic Bronchitis?
Unlike acute bronchitis, where virus or bacteria is most likely the cause, there is no organism that is recognized as the cause of chronic bronchitis.' The most common cause of chronic bronchitis is smoking.' Most long term smokers experience the symptoms of chronic bronchitis at one time or another throughout their lives.' Other causes of chronic bronchitis may be bacterial or viral infections, pollution of the environment, or the breathing of certain chemicals.' Chronic bronchitis has also been associated with various pulmonary diseases including emphysema, asthma, fibrosis, and tuberculosis.

How is Chronic Bronchitis Diagnosed?  Your physician may ask you to provide your medical history, and conduct a physical examination.' If more tests need to be run, some of these may include: :D.

Pulmonary Function Tests
These tests measure the lungs' ability to trade oxygen and carbon dioxide.' These tests will probably be run using special equipment, and consist of you breathing into a tube that computes the measurements.

Cough.' This cough may be subtle or harsh, but with all cases of bronchitis there is some coughing present.  - Expectoration.' Expectoration is the coughing up, or spitting out of mucus due to over production, caused by bronchitis. People are inclined to think that some matter found here that is pertaining to Bronchitis Smoking is false. However, rest is assured, all that is written here is true!

Other Tests
May include X-Ray's, CT scans or other internal imaging tests.  If you have the symptoms described in this article, you are advised to consult your personal physician as soon as possible to have your condition properly diagnosed and treated.

The fluoroquinolones are a relatively new group of antibiotics. Fluoroquinolones were first introduced in 1986, but they are really modified quinolones, a class of antibiotics, whose accidental discovery occurred in the early 1960.

Fourth Generation
The fourth-generation fluoroquinolones add significant antimicrobial activity against anaerobes while maintaining the gram-positive and gram-negative activity of the third-generation drugs. They also retain activity against Pseudomonas species comparable to that of ciprofloxacin. The fourth-generation fluoroquinolones include trovafloxacin (Trovan). You will learn the gravity of Chronic Bronchitis once you are through reading this matter. Chronic Bronchitis are very important, so learn its importance.

Fluoroquinolones are approved for use only in people older than 18. They can affect the growth of bones, teeth, and cartilage in a child or fetus. The FDA has assigned fluoroquinolones to pregnancy risk category C, indicating that these drugs have the potential to cause teratogenic or embryocidal effects. Giving fluoroquinolones during pregnancy is not recommended unless the benefits justify the potential risks to the fetus. These agents are also excreted in breast milk and should be avoided during breast-feeding if at all possible.

Second Generation
The second-generation fluoroquinolones have increased gram-negative activity, as well as some gram-positive and atypical pathogen coverage. Compared with first-generation quinolones, these drugs have broader clinical applications in the treatment of complicated urinary tract infections and pyelonephritis, sexually transmitted diseases, selected pneumonias and skin infections.

The fluoroquinolones are a family of synthetic, broad-spectrum antibacterial agents with bactericidal activity. The parent of the group is nalidixic acid, discovered in 1962 by Lescher and colleagues. The first fluoroquinolones were widely used because they were the only orally administered agents available for the treatment of serious infections caused by gram-negative organisms, including Pseudomonas species.

Urinary tract infections (norfloxacin, lomefloxacin, enoxacin, ofloxacin, ciprofloxacin, levofloxacin, gatifloxacin, trovafloxacin) Lower respiratory tract infections (lomefloxacin, ofloxacin, ciprofloxacin, trovafloxacin) Skin and skin-structure infections (ofloxacin, ciprofloxacin, levofloxacin, trovafloxacin) Urethral and cervical gonococcal infections (norfloxacin, enoxacin, ofloxacin, ciprofloxacin, gatifloxacin, trovafloxacin) Prostatitis (norfloxacin, ofloxacin, trovafloxacin) Acute sinusitis (ciprofloxacin, levofloxacin, gatifloxacin, moxifloxacin (Avelox), trovafloxacin) Acute exacerbations of chronic bronchitis (levofloxacin, sparfloxacin (Zagam), gatifloxacin, moxifloxacin, trovafloxacin) Community-acquired pneumonia (levofloxacin, sparfloxacin, gatifloxacin, moxifloxacin, trovafloxacin) People have an inclination of bragging on the knowledge they have on any particular project. However, we don't want to brag on what we know on Chronic Bronchitis, so long as it proves useful to you, we are happy.

Fluoroquinolones Advantages:
Ease of administration Daily or twice daily dosing  Excellent oral absorption Excellent tissue penetration  Prolonged half-lives Significant entry into phagocytic cells Efficacy Overall safety We have gone through extensive research and reading to produce this article on Chronic Bronchitis. Use the information wisely so that the information will be properly used.

Third Generation
The third-generation fluoroquinolones are separated into a third class because of their expanded activity against gram-positive organisms, particularly penicillin-sensitive and penicillin-resistant S. pneumoniae, and atypical pathogens such as Mycoplasma pneumoniae and Chlamydia pneumoniae. Although the third-generation agents retain broad gram-negative coverage, they are less active than ciprofloxacin against Pseudomonas species.

Gastrointestinal Effects
The most common adverse events experienced with fluoroquinolone administration are gastrointestinal (nausea, vomiting, diarrhea, constipation, and abdominal pain), which occur in 1 to 5% of patients.  CNS effects. Headache, dizziness, and drowsiness have been reported with all fluoroquinolones. Insomnia was reported in 3-7% of patients with ofloxacin. Severe CNS effects, including seizures, have been reported in patients receiving trovafloxacin. Seizures may develop within 3 to 4 days of therapy but resolve with drug discontinuation. Although seizures are infrequent, fluoroquinolones should be avoided in patients with a history of convulsion, cerebral trauma, or anoxia. No seizures have been reported with levofloxacin, moxifloxacin, gatifloxacin, and gemifloxacin. With the older non-fluorinated quinolones neurotoxic symptoms such as dizziness occurred in about 50% of the patients.  Phototoxicity. Exposure to ultraviolet A rays from direct or indirect sunlight should be avoided during treatment and several days (5 days with sparfloxacin) after the use of the drug. The degree of phototoxic potential of fluoroquinolones is as follows: lomefloxacin > sparfloxacin > ciprofloxacin > norfloxacin = ofloxacin = levofloxacin = gatifloxacin = moxifloxacin. Musculoskeletal effects. Concern about the development of musculoskeletal effects, evident in animal studies, has led to the contraindication of fluoroquinolones for routine use in children and in women who are pregnant or lactating.  Tendon damage (tendinitis and tendon rupture). Although fluoroquinolone-related tendinitis generally resolves within one week of discontinuation of therapy, spontaneous ruptures have been reported as long as nine months after cessation of fluoroquinolone use. Potential risk factors for tendinopathy include age >50 years, male gender, and concomitant use of corticosteroids. Hepatoxicity. Trovafloxacin use has been associated with rare liver damage, which prompted the withdrawal of the oral preparations from the U.S. market. However, the IV preparation is still available for treatment of infections so serious that the benefits outweigh the risks. Cardiovascular effects. The newer quinolones have been found to produce additional toxicities to the heart that were not found with the older compounds. Evidence suggests that sparfloxacin and grepafloxacin may have the most cardiotoxic potential. Hypoglycemia/Hyperglycemia. Recently, rare cases of hypoglycemia have been reported with gatifloxacin and ciprofloxacin in patients also receiving oral diabetic medications, primarily sulfonylureas. Although hypoglycemia has been reported with other fluoroquinolones (levofloxacin and moxifloxacin), the effects have been mild. Hypersensitivity. Hypersensitivity reactions occur only occasionally during quinolone therapy and are generally mild to moderate in severity, and usually resolve after treatment is stopped. After many hopeless endeavors to produce something worthwhile on Chronic Bronchitis, this is what we have come up with. We are very hopeful about this!

All of the fluoroquinolones are effective in treating urinary tract infections caused by susceptible organisms. They are the first-line treatment of acute uncomplicated cystitis in patients who cannot tolerate sulfonamides or TMP, who live in geographic areas with known resistance > 10% to 20% to TMP-SMX, or who have risk factors for such resistance.

The newer fluoroquinolones have a wider clinical use and a broader spectrum of antibacterial activity including gram-positive and gram-negative aerobic and anaerobic organisms. Some of the newer fluoroquinolones have an important role in the treatment of community-acquired pneumonia and intra-abdominal infections. If you find anything extra mentioning about Chronic Bronchitis, do inform us. It is only through the exchange of views and information will we learn more about Chronic Bronchitis.

Conditions treated with Fluoroquinolones: indications and uses  The newer fluoroquinolones have a wider clinical use and a broader spectrum of antibacterial activity including gram-positive and gram-negative aerobic and anaerobic organisms. Some of the newer fluoroquinolones have an important role in the treatment of community-acquired pneumonia and intra-abdominal infections. The serum elimination half-life of the fluoroquinolones range from 3 -20 hours, allowing for once or twice daily dosing. Get more familiar with Chronic Bronchitis once you finish reading this article. Only then will you realize the importance of Chronic Bronchitis in your day to day life.

Because of their expanded antimicrobial spectrum, third-generation fluoroquinolones are useful in the treatment of community-acquired pneumonia, acute sinusitis and acute exacerbations of chronic bronchitis, which are their primary FDA-labeled indications. The third-generation fluoroquinolones include levofloxacin, gatifloxacin, moxifloxacin and sparfloxacin. Nothing abusive about Chronic Bronchitis have been intentionally added here. Whatever it is that we have added, is all informative and productive to you.

Side Effects
The fluoroquinolones as a class are generally well tolerated. Most adverse effects are mild in severity, self-limited, and rarely result in treatment discontinuation. However, they can have serious adverse effects.

Fluoroquinolones disadvantages:    Tendonitis or tendon rupture  Multiple drug interactions Not used in children Newer quinolones produce additional toxicities to the heart that were not found with the older agents

First Generation
The first-generation agents include cinoxacin and nalidixic acid, which are the oldest and least often used quinolones. These drugs had poor systemic distribution and limited activity and were used primarily for gram-negative urinary tract infections. Cinoxacin and nalidixic acid require more frequent dosing than the newer quinolones, and they are more susceptible to the development of bacterial resistance.